However, both the increase in transcript and immunohistochemical staining can be rescued with the inhibition of glucosylceramide synthase (GCS), the enzyme that produces beta-D-glucosylceramide, the precursor to the sphingolipid species that accumulate in Sandhoff disease [117]. This evidence concerns the gene UGCG and Sandhoff disease.